Back to Home > Business > Press Releases > Press Releases - Medical

Press Releases - Medical  

More Stories

  • First Incisionless Natural Orifice Surgery Completed on a Child

    EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that its innovative EsophyX(R) device was used to complete the first ever incisionless transoral NOS surgery on a child. The 10-year-old boy had suffered from chronic GERD (gastroesophageal reflux disease) for years and was successfully treated by Todd Overcash, M.D., at Munroe Medical Center in Ocala, Florida, who performed a TIF (Transoral Incisionless Fundoplication) surgery using the EsophyX device.

  • Axiom Worldwide Brings Home Another Win for the U.S. in China by Receiving SFDA Certification for the DRX9000(TM)!

    On July 11, 2008 Axiom Worldwide received the SFDA (State Food and Drug Administration) Registration Certificate in China for the DRX9000(TM). SFDA, the Chinese equivalent of the US Food and Drug Administration (FDA), is making greater efforts to create a better medical device regulatory environment.

  • XenaCare Merger with Sun Packing

    XenaCare Holdings Inc. (OTCBB:XCHO) ("XCHO"), owners of nationally branded OTC nutritional products, and the developer of the SunPill(TM), announced in a filing with the Securities & Exchange Commission the planned merger between itself and Sun Packing, Inc., a Texas Corporation. The merger, expected to be completed October 2008, puts Sun shareholders in control of 50.1% of the shares in the surviving company and contemplates a name change to more reflect the company's current businesses.

  • BancTec to Demonstrate New Transactional Content Management Solution at TAWPI 2008 Forums and Expo

    BancTec, a global provider of advanced, high-volume document and payment processing solutions and services, will feature its next generation global platform for managing multiple streams of in-bound information -- CenterVision(TM) -- at the TAWPI 2008 Forums and Expo, August 24-27 at Disney's Contemporary Resort in Orlando. BancTec will be located in Booth 401.

  • Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration

    Cryo-Cell International, Inc. and EndGenitor Technologies, Inc. are pleased to announce a new research collaboration to co-develop a combined cellular platform therapeutic for rapidly forming vasculature in injured tissues. Currently, intense research into the mechanisms of initiation of angiogenesis and the repair of damaged vasculature is underway in order to identify the participating molecular and cellular components involved. Greater understanding of this highly-complex process is paving the way to identify novel potential therapeutics for treating cancer and cardiovascular disease.

  • Forward Announces Engagement of Investment Banking Firm to Identify and Evaluate Targets for Acquisition

    Forward Industries, Inc. (NASDAQ:FORD), a designer and distributor of custom carrying case solutions, today announced that it has engaged vFinance Investments, Inc., a nationally recognized investment banking firm based in Boca Raton, Florida, as its exclusive financial advisor to assist it in identifying and evaluating prospective targets for acquisition by Forward in a business combination.

  • Zounds Brings New Hearing Technology to The Villages

    Zounds Hearing, a unique manufacturing and retail company focused on providing hearing aids with state-of-the-art fidelity, affordable price point and professional service has opened its newest Florida hearing center in The Villages community. An official celebratory community open house with Zounds' founder, Sam Thomasson, is scheduled for Thursday, August 28, from 12:30 p.m. -- 2:00 p.m.

  • Bioheart, Inc. Announces Additional Funding Support

    Bioheart, Inc., (Nasdaq: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, today announced receipt of a $1 million unsecured loan from Rogers Telecommunications Limited. This loan is payable upon the later of three months or Bioheart's repayment of its loan from BlueCrest Capital. In addition, under certain circumstances, the Company may be permitted to pay outstanding interest and principal in shares of its common stock. The loan will be used for Bioheart's ongoing clinical and business operations, as the Company continues to actively pursue additional investment support.

  • No Matter How You Analyze It...Record 380% Growth Impressive Even in Healthcare Staffing

    Medical Connections (OTC Bulletin Board: MCTH) announced today that in a period during which staffing industry firms grew at record rates, one company managed to soar above all the rest - posting figures of more than double those of its nearest competitor.

  • [video] Charles Fust, CEO of SinoFresh HealthCare, Inc. Discusses Preliminary Test Results From In Vivo Pilot Study on WallSt.net's 3-Minute Press Show

    SinoFresh HealthCare, Inc. (OTC Bulletin Board: SFSH), a developer and marketer of innovative upper respiratory system therapies, today announced that the company's CEO, Charles Fust, is featured in an exclusive interview on WallSt.net's 3-Minute Press Show.

  • PSS World Medical Holds Annual Meeting of Shareholders

    PSS World Medical, Inc. (NASDAQ GS: PSSI) announced that it held its annual meeting of shareholders today in Jacksonville, Florida. At the meeting, the shareholders re-elected Charles E. Adair, Alvin R. Carpenter and Stephen H. Rogers as directors of the Company to terms expiring in 2011. In addition, in accordance with the Company's director retirement policy, T. O'Neal Douglas retired from the Board effective today. Mr. Douglas has served on the Board since October 2000 and previously from July 1993 through September 1999.

  • Attitude Drinks Incorporated Announces Partnership with Nutraceutical Discoveries, Inc. to Create Metabolic Dairy Beverage

    Attitude Drinks Incorporated (OTC Bulletin Board: ATTD), an innovative beverage, brand development and marketing company, announced today a partnership with Nutraceutical Discoveries, Inc., creator of Innutria(TM), to develop and introduce a cutting edge, functional dairy beverage with enhanced metabolic effects. This license agreement became effective August 19, 2008.

  • Restylane or Juvederm: Two Rivals Go to the Mats in the Never Ending Battle of the Wrinkle Remover Competition

    There is now a new competitor, waiting in the wings with a different technique and willing to take on both of these ever more popular players. Enter the Galvanic Spa System II by Nu Skin Enterprises based in Provo, Utah. The results of galvanic current technique promises to become a major method for treatment of skin without the use of injections or other invasive, expensive and painful techniques such as Botox.

  • ArquitectonicaGEO Brings Landscape Design to Projects for Booming Latin American Seniors Market

    Miami-based ArquitectonicaGEO, the landscape architecture firm led by globally renowned designer Laurinda Spear, FAIA, ASLA, has announced the firm's expansion into the U.S., Spanish and Latin American markets for senior housing, retirement homes and assisted-living facilities.

  • Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss

    Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) today reported that animal data from a new study sponsored by scientists at the U.S. Department of Energy's Brookhaven National Laboratory appears to demonstrate that taking vigabatrin leads to rapid weight loss and reduced food intake. The data was published online as of August 20, 2008 in the journal Synapse, a prestigious peer-reviewed neuroscience publication.

  • Eye Allergies Nothing to Sneeze at This Fall

    Come late summer, some 10 to 20 percent of Americans begin to suffer from ragweed allergy, or hay fever. In addition to symptoms of sneezing, stuffy or runny nose, allergic reactions involving the eyes are a major distraction for many allergy sufferers.

  • Mr. Diabetes(R) Says Prevention is Best Solution for Diabetes Epidemic

    For the past eight years Andy Mandell -- Mr. Diabetes(R) has been a man with one mission: he's been walking the 10,000 mile perimeter of the United States raising awareness about the dangers of diabetes and letting people know they can prevent it from happening to them.

  • Alan James Group Launches Enhanced Websites for Existing Nutritional Supplement Product Line

    Alan James Group (AJG), a wholly owned subsidiary of Interleukin Genetics, Inc. (Amex: ILI), announced today that it has launched several new websites for its line of branded nutritional supplements, including Ginsana(R), Ginkoba(R), Venastat(R), Optiform SAM-e(R), Cransana(R) and Ginsana Gold Multiplex(R). AJG markets items in multiple categories in the Food, Drug and Mass (FD&M) channels, including Energy, Memory, Leg Vein Health and Heart Health. AJG also distributes Kyolic(R) in the FD&M channels under an agreement with Wakunaga of America Co. Ltd.

  • Year-Round Sun Protection from a Pill

    XenaCare Holdings Inc. (OTC BB: XCHO) announced today that their innovative new product called the SunPill(R) has moved into the retail sales environment, both online and in select drug store chains supported by a national TV campaign.

  • Noven Signs License and Supply Agreements with Procter & Gamble Pharmaceuticals for Patches to Treat HSDD

    Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that it has entered into global license and supply agreements with Procter & Gamble Pharmaceuticals, Inc. ("P&GP"), a subsidiary of The Procter & Gamble Company, relating to the development and commercialization of prescription transdermal patches for the treatment of Hypoactive Sexual Desire Disorder ("HSDD") in women.

Miami Top Jobs

    Quick Job Search

    Enter Keyword(s): Enter City: Select a State: Select a Category: Advanced Job Search Search by Category